Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 849, pseudogene (RN7SL849P) is a human pseudogene derived from 7SL RNA, the RNA component of the signal recognition particle (SRP), which is essential for co-translational targeting of secretory and membrane proteins to the endoplasmic reticulum[1][3]. Pseudogenes like RN7SL849P are genomic sequences that closely resemble functional genes but have lost their protein-coding capacity due to mutations such as truncations, insertions, or deletions[6]. The human genome contains hundreds of 7SL-related pseudogenes, most of which are truncated copies of 7SL RNA that likely arose through retrotransposition events[5][7]. These pseudogenes are not known to produce functional RNA and are not considered therapeutic targets. They are typically classified as noncoding genomic elements rather than as receptors, enzymes, transporters, or other drug targets. There is no evidence linking RN7SL849P specifically to biological processes, diseases, drugs, or biomarkers; its primary scientific interest lies in evolutionary and genomic studies[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 849, pseudogene (RN7SL849P).